T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Chubb
CB
$133B
| $59M | 0.01% |
580,450
+6,480
| +1% | +$698K |
|
|
CLC
777
DELISTED
Clarcor
CLC
| $58.3M | 0.01% |
936,056
+326,329
| +54% | +$20.8M |
|
|
QLIK
778
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $57.9M | 0.01% |
1,656,520
+1,629,220
| +5,968% | +$57.7M |
|
|
YOKU
779
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
| $57.9M | 0.01% |
2,358,878
-455,100
| -16% | -$10.3M |
|
780
Monster Beverage
MNST
$91.4B
| $57.8M | 0.01% |
5,174,088
-4,544,760
| -47% | -$50.7M |
|
|
SNV
781
DELISTED
Synovus
SNV
| $57.7M | 0.01% |
1,871,789
+2,406
| +0.1% | +$69.6K |
|
|
AVX
782
DELISTED
AVX Corporation
AVX
| $57.6M | 0.01% |
4,277,452
+134,110
| +3% | +$1.9M |
|
783
Silicon Laboratories
SLAB
$7.28B
| $57.6M | 0.01% |
1,065,940
-170,790
| -14% | -$9.13M |
|
|
ZU
784
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
| $57.4M | 0.01% |
4,403,622
-948,519
| -18% | -$12.9M |
|
785
Travelers Companies
TRV
$77.2B
| $57.1M | 0.01% |
590,957
+18,900
| +3% | +$1.94M |
|
|
RLYP
786
DELISTED
RELYPSA INC COM
RLYP
| $57.1M | 0.01% |
1,725,639
-63,510
| -4% | -$2.18M |
|
|
KTWO
787
DELISTED
K2M Group Holdings, Inc
KTWO
| $56.7M | 0.01% |
2,362,010
-9,400
| -0.4% | -$224K |
|
788
Ares Capital
ARCC
$14.5B
| $56.6M | 0.01% |
3,436,100
-1,070,740
| -24% | -$17.9M |
|
|
WPP
789
DELISTED
WAUSAU PAPER CORP.
WPP
| $56.2M | 0.01% |
6,125,670
+179,736
| +3% | +$1.73M |
|
790
HDFC Bank
HDB
$119B
| $56.2M | 0.01% |
3,714,776
-202,444
| -5% | -$2.94M |
|
791
TriMas Corp
TRS
$1.39B
| $56M | 0.01% |
2,376,267
+3,514
| +0.1% | +$83.7K |
|
|
RAI
792
DELISTED
Reynolds American Inc
RAI
| $55.8M | 0.01% |
1,495,752
+430,176
| +40% | +$16.1M |
|
793
Northrop Grumman
NOC
$81.6B
| $55.7M | 0.01% |
351,169
+3,100
| +0.9% | +$496K |
|
|
TIF
794
DELISTED
Tiffany & Co.
TIF
| $55.7M | 0.01% |
606,680
-311,169
| -34% | -$27.8M |
|
795
Saia
SAIA
$10.1B
| $55.7M | 0.01% |
1,417,430
+700,760
| +98% | +$29M |
|
796
Albany International
AIN
$1.82B
| $55.6M | 0.01% |
1,396,883
-2,000
| -0.1% | -$80.2K |
|
|
CMA
797
DELISTED
Comerica
CMA
| $55.4M | 0.01% |
1,078,723
-1,135,842
| -51% | -$55.3M |
|
798
Myers Industries
MYE
$1.25B
| $55.3M | 0.01% |
2,910,555
+3,900
| +0.1% | +$68.8K |
|
799
Skyworks Solutions
SWKS
$10.5B
| $55.3M | 0.01% |
530,971
+6,662
| +1% | +$674K |
|
800
Woodward
WWD
$21.2B
| $55M | 0.01% |
999,820
-61,570
| -6% | -$3.16M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.